Contribute Try STAT+ Today

Top of the morning, and a fine one it is. Clear blue skies and a shiny sun are enveloping the comfy Pharmalot campus, where the short person is hunched over a laptop and the spirited official mascot is chasing varmints. As for us, we are firing up the trusty coffee kettle to brew more cups of stimulation. For those who track this sort of thing, our choice today is maple bourbon. Meanwhile, we have assembled a few items of interest for you. We hope your day is productive and you conquer the world. And of course, do stay in touch. We appreciate your juicy tips and insights. …

A European Medicines Agency official told an Italian news site that there is a link between the AstraZeneca (AZN) Covid-19 vaccine and blood clots, Agence France Presse writes. Persistent questions on whether rare but serious blood clots among those getting the shot are more frequent than in the general population have undermined confidence in the beleaguered vaccine. After several countries suspended use of the vaccine, the EMA said the benefits outweigh the risks and it should remain in use, but an updated assessment is expected this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Hmmm , a thought about Catalent. If memory serves, that facility is also supporting J&J production. A further … indictment of the Emergent facility that had to jettison the AstraZeneca vaccine production to do things properly?

Comments are closed.